Barrington Research Cuts Henry Schein (NASDAQ:HSIC) Price Target to $86.00

Henry Schein (NASDAQ:HSIC) had its price target dropped by equities researchers at Barrington Research from $90.00 to $86.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Barrington Research’s price objective would indicate a potential upside of 29.17% from the stock’s previous close.

Other equities research analysts have also issued research reports about the stock. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Finally, StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus price target of $79.80.

Henry Schein Trading Up 2.0 %

Shares of NASDAQ HSIC opened at $66.58 on Tuesday. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $8.16 billion, a price-to-earnings ratio of 27.40, a PEG ratio of 2.13 and a beta of 0.87. The business’s 50 day moving average price is $67.89 and its 200-day moving average price is $71.55.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the company earned $1.10 earnings per share. On average, sell-side analysts expect that Henry Schein will post 4.74 earnings per share for the current year.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Hedge funds and other institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc lifted its position in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares in the last quarter. Investment Management Corp VA ADV purchased a new position in Henry Schein in the 4th quarter valued at approximately $32,000. Rakuten Securities Inc. acquired a new position in shares of Henry Schein in the first quarter worth $34,000. Venturi Wealth Management LLC grew its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Finally, Quent Capital LLC increased its position in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.